Skip to main content
padlock icon - secure page this page is secure

Open Access Coma hiperosmolar associado ao transplante de fígado Hyperosmolar coma associated with liver transplantation

Download Article:

The full text article is available externally.

The article you have requested is supplied via the DOAJ. View from original source.

INTRODUÇÃO: O diagnóstico diferencial dos pacientes inconscientes sempre inclui o coma hiperosmolar hiperglicêmico não-cetótico. RELATO DE CASO: Paciente do sexo feminino, 22 anos, tipo sangüíneo O+, branca, natural e procedente do Recife - PE com queixa de icterícia e astenia há um mês. Ao exame físico, havia icterícia 3+/4+, desnutrição leve (IMC 17,5) e asterixis. Os exames laboratoriais sugeriram hepatite fulminante. Após 12 horas da inclusão na lista de espera pelo transplante, recebeu enxerto de fígado de doador cadáver, mediante o uso de técnica de piggback sem intercorrências. No 10º dia pós-operatório evoluiu com trombose de artéria hepática (TAH), diagnosticada por ultra-som com doppler de artéria hepática. Após 48 horas foi retransplantada sem intercorrências. A partir do 13º dia de pós-operatório, evoluiu com hiperglicemia grave (> 600 mg/dl) e alteração do nível de consciência (9 pontos na escala de coma de Glasgow). Osmolaridade sérica nesse momento igual a 309 mOsm/kgH2O. O nível sérico de tacrolimus nesse dia foi de 11 ng/dl. Coma hiperosmolar hiperglicêmico não-cetótico foi tratado clinicamente por 48 horas. Recebeu alta no 30º dia de pós-operatório do retransplante, sem diabete mellitus. CONCLUSÃO: O coma hiperosmolar é um evento raro no pós-operatório de transplante de fígado e pode modificar a evolução do paciente.
BACKGROUND: The literature described an increased incidence of gastrointestinal stromal tumors (GISTs) in patients with neurofibromatosis type 1. These tumors typically occur in the small intestine, and frequently are multiple. Often the behavior of the tumor in this association is more favorable than in sporadic cases. CASE REPORT: Incidental diagnosis of GIST was done in a patient with neurofibromatosis type 1 during treatment for acute abdomen. Trans-operatively was identified a retrocecal perforated appendicitis and a neoplastic mass in the proximal jejunum. The lesion occupied approximately 70% of the circumference of the organ and had no invasion of adjacent structures. Moreover, there were dozens of small nodules scattered throughout the length of the jejunum and ileum. The pathology revealed malignancy consistent with GIST, with moderate degree of atypia, low mitotic index (<5 / 50) and absence of necrosis. In immunohistochemical analysis, the neoplastic cells were positive for CD-34 and CD-117 (c-KIT), and negative for desmin. After surgery, the use of Imatinib chemotherapy was indicated. After a follow-up period of 12 months, the patient showed no signs of recurrence. CONCLUSION: GISTs should be considered in the presence of abdominal mass and neurofibromatosis type 1, affecting mainly small bowel. Sometimes Imatinib can be administered with good results in the control of the disease.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Document Type: Research Article

Publication date: January 1, 2009

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more